Swiss Paraplegic Research, Nottwil, Switzerland,
University of Lucerne, Health Sciences and Health Policy, Luzern, Switzerland,
Neuroepidemiology. 2019;52(3-4):205-213. doi: 10.1159/000496976. Epub 2019 Feb 14.
Traumatic spinal cord injuries (TSCI) are a neurological condition associated with reduced well-being, increased morbidity and reductions in life expectancy. Estimates of all-cause and cause-specific mortality can aid in identifying targets for prevention and management of contributors for premature mortality.
To compare all-cause and cause-specific rates of mortality to that of the Swiss general population; to identify differentials in risk of cause-specific mortality according to lesion characteristics.
All-cause and cause-specific standardized mortality ratios (SMRs) were calculated using data from the Swiss Spinal Cord Injury cohort study. Cause-specific subhazard ratios were estimated within a competing risk framework using flexible parametric survival models.
Between 1990 and 2011, 2,492 persons sustained a TSCI, of which 379 died. Persons with TSCI had a mortality rate more than 2 times higher than that of the Swiss general population (SMR 2.32; 95% CI 2.10-2.56). Tetraplegic lesions were associated with an increased risk of mortality due to respiratory and cardiovascular diseases, infections, and accidents. Cause-specific SMRs were notably elevated for SCI-related conditions such as urinary tract infections (UTIs) and septicemia.
Elevated SMRs due to cardiovascular disease, UTIs and septicemia-related mortality suggest the need for innovation when managing associated secondary health conditions.
外伤性脊髓损伤(TSCI)是一种与健康状况下降、发病率增加和预期寿命缩短相关的神经疾病。全因和病因特异性死亡率的估计可以帮助确定预防和管理过早死亡的贡献因素的目标。
比较全因和病因特异性死亡率与瑞士普通人群的死亡率;根据损伤特征确定病因特异性死亡率的差异。
使用瑞士脊髓损伤队列研究的数据计算全因和病因特异性标准化死亡率比(SMR)。使用灵活的参数生存模型在竞争风险框架内估计病因特异性亚危险比。
1990 年至 2011 年期间,共有 2492 人发生外伤性脊髓损伤,其中 379 人死亡。与瑞士普通人群相比,TSCI 患者的死亡率高出 2 倍以上(SMR 2.32;95%CI 2.10-2.56)。四肢瘫痪损伤与呼吸道和心血管疾病、感染和事故导致的死亡风险增加有关。与 SCI 相关的疾病(如尿路感染(UTI)和败血症)的病因特异性 SMR 显著升高。
心血管疾病、UTI 和败血症相关死亡率导致的 SMR 升高表明,在管理相关继发性健康状况时需要创新。